Search

everythinglearnresearchcommunity

for

Search:↓

Astilbin can potentially calm overactive immune responses, like in Type 1 Diabetes, by suppressing certain cell activities and reducing inflammation.

Interferon, especially alfa interferon, is an effective treatment for cutaneous T-cell lymphoma with manageable side effects.

The document concludes that treatment for cutaneous T-cell lymphoma should be customized to each patient's disease stage, balancing benefits and side effects, with no cure but many patients living long lives.

The document concludes that DAB389-IL2 is promising for treating refractory cutaneous T-cell lymphoma, but more research is needed on its effectiveness and side effect management.

Memory T cells in the skin balance staying put and moving into the blood, clustering around hair follicles, and increasing in number after infection.

Maintaining DNA integrity in stem cells is crucial to prevent aging and cancer.

Antroquinonol may help prevent skin depigmentation by suppressing certain immune cells.

Frontal fibrosing alopecia may affect nails and could be a type of lichen planus, treatable with certain medications.

Alopecia areata is caused by immune attacks on hair follicles, affecting hair growth and quality of life.

JAK inhibitors are a promising new treatment for hair loss and nail problems in alopecia areata.

CD8+ T cells attack hair follicle stem cells, causing scarring and hair loss in Discoid Lupus.

Ebastine may help regrow hair in alopecia areata patients.

FOXN1 is crucial for thymus development and immune response in Xenopus laevis.

Targeted cytokine treatments may help with alopecia areata, but more research is needed.

New treatments targeting the JAK signaling pathway, especially JAK inhibitors, show promise for alopecia areata.

A woman's progressive hair loss was correctly diagnosed as a rare condition called fibrosing alopecia in a pattern distribution after initially being mistaken for a more common type.

Different types of sun exposure damage skin cells and immune cells, with chronic exposure leading to more severe and lasting damage.

Both Th1 and Th2 immune responses are increased in alopecia areata, with Th2 response more strongly linked to how severe the disease is.

UV light helped human hair transplants survive in mice without broad immunosuppression.

Scientists are still unsure what triggers the immune system to attack hair follicles in Alopecia areata.

People with alopecia areata are more likely to have other immune-related conditions.

Alopecia Areata is treated with drugs and therapies to reduce inflammation and immune response.

RANKL improves the immune response against herpes simplex virus by enhancing T cell activation and could help develop better treatments or vaccines.

Exosomes from certain cells can improve hair regrowth by changing the immune response.

Men are more likely to have severe respiratory viral infections like COVID-19 due to hormonal and genetic differences, while women generally have stronger immune responses.

Clonally expanded CD8+ T cells cause alopecia areata.

Certain immune cells contribute to severe hair loss in chronic alopecia areata, with Th17 cells possibly having a bigger impact than cytotoxic T cells.

A specific enzyme is essential for proper hair follicle stem cell development and healthy skin.

Researchers found that hair follicle stem cells can become squamous cell carcinoma due to Ras activation, which could lead to new treatments.

Ebastine may promote hair regrowth by increasing cell growth through the ERK pathway.